Le Lézard
Classified in: Health
Subjects: TDS, PET, ANW

Service and Working Animals Receive Free Eye Exams Across the U.S.


Registration Opens on April 1, 2024

MERIDIAN, Idaho, April 2, 2024 /PRNewswire/ -- The American College of Veterinary Ophthalmologists® (ACVO) is proud to announce registration opens for the 15th annual National Service Animal Eye Exam Event, sponsored by Epicur Pharma®, April 1 to 30, 2024. The event brings together more than 250 board-certified ACVO Diplomates across approximately 170 cities in the U.S.A., Canada, Hong Kong, Puerto Rico, and the United Kingdom to provide screening free eye exams to Service and Working Animals in May. Appointment availability can be limited and must be made by Service and Working Animal handlers during the registration period from April 1st to 30th, 2024.

"The ACVO/Epicur National Service Animal Eye Event is one that my colleagues and I look forward to all year. It not only gives us a chance to give back to some of the most deserving members of our human and animal community, but it allows us a critical opportunity to protect the physical well-being and the livelihood of the animals who are working to care for their humans. This event allows us to engage with a subset of the population that we might otherwise minimally have the opportunity to interact with, to offer thanks for their service, and to offer proactive care. Although most of the working animals that we screen have normal, healthy eye exams, we have the ability to identify and resolve minor issues quickly, and on rare occasion, identify and treat issues that could result in blindness and pain. These screenings offer a different and more specialized level of eye examination than are possible during a primary care or wellness exam, and we hope that every working animal will take advantage of this opportunity with a board-certified ophthalmologist each year," said ACVO Membership, Promotion, & Outreach Committee Chairperson, Dr. Elizabeth Lutz, DVM, DACVO.

Preview the participating locations at acvoeyeexam.org/participating-cities. Note that locations change year to year. To register, visit acvoeyeexam.org/qualifications-expectations. Once registered, the owner/handler will receive a link to a list of participating clinics with their contact information to schedule an appointment. The owner/handler must provide the registration number to the clinic when making an appointment. Please note that appointments are not confirmed until the owner/handler has contacted the clinic directly. Appointments will be held throughout May 2024, and dates and times may vary by location based on the availability of exams. Limited appointments are available, plan to register early.

To qualify for a free eye exam, animals must be active, currently working, formally trained Service, Working, or formally trained therapy animals (with written proof of therapy training & registration). Qualification paperwork for the training and current working status of either the Service Animal or registered therapy animal must be provided to the clinic at the time of the exam, in addition to the registration number provided in the confirmation email. For information on what to expect during the exam, visit acvoeyeexam.org/qualifications-expectations.

The American College of Veterinary Ophthalmologists® is an approved veterinary specialty organization of the American Board of Veterinary Specialties that board certifies veterinarians as ophthalmologists. The 2024 ACVO National Service Animal Eye Exam Event is sponsored by Epicur Pharma®. For more information about the ACVO and its boarded veterinary ophthalmologists, visit www.ACVO.org. Visit Epicur Pharma® at www.epicurpharma.com.

ACVO MEDIA CONTACT: ACVO® Service Animal Office | [email protected]

SOURCE American College of Veterinary Ophthalmologists (ACVO)


These press releases may also interest you

at 03:05
In Q1 2024, LEO Pharma delivered a revenue growth of 13% in constant exchange rates (CER). The dermatology portfolio saw accelerated growth in revenue of 16%. The acquisition of TMB-001 to the treatment of congenital ichthyosis added a late-stage...

at 02:22
Hansa Biopharma AB (publ), ("Hansa" or the "Company") (STO: HNSA) today announced that the company's registered share capital and number of shares and votes have increased through the issue of 10,474,740 new ordinary shares on 12 April 2024, whereby...

at 02:20
Vicore Pharma Holding (STO:VICO) Stockholm, May 3 2024- Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), publishes the interim...

2 mai 2024
The report titled "Muscle Stimulator Market by Technique (Burst Mode Alternating Current, Functional Electrical Stimulation, Interferential), Modality (Handheld, Portable, Table Top), Area, Application, End-User - Global Forecast 2024-2030" is now...

2 mai 2024
Epredia, a global leader in precision cancer diagnostics and subsidiary of PHC Holdings Corporation (TSE: 6523), and NovaScan, Inc., a company that develops breakthrough technology for cancer detection and stratification, announce that they have...

2 mai 2024
The United States of America and ReNew Health Group LLC have settled a nursing home whistleblower claim involving allegations that the nursing home chain submitted false Medicare claims. We need transparency and accountability in our nursing homes....



News published on and distributed by: